TAGAMET(CIMETIDINE HYDROCHLORIDE) - 美国FDA药品数据库

药品名称	TAGAMET
申请号	017939	产品号	002
活性成分	CIMETIDINE HYDROCHLORIDE	市场状态	停止上市
剂型或给药途径	INJECTABLE;INJECTION	规格	EQ 300MG BASE/2ML
治疗等效代码		参比药物	否
批准日期	Approved Prior to Jan 1, 1982	申请机构	GLAXOSMITHKLINE
化学类型	New dosage form	审评分类	Priority review drug

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

与本品相关的市场独占权保护信息
独占权代码	失效日期
无
历史市场独占权保护信息
无

与药品注册相关的信息
申请号	修订号	审批结论	公开文档类型	文档创建时间	获取文档
无

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
017939	086	AP	1997/04/15	Control Supplement
017939	085	AP	1995/02/22	Labeling Revision
017939	084	AP	1993/11/10	Manufacturing Change or Addition
017939	083	AP	1993/06/08	Manufacturing Change or Addition
017939	081	AP	1992/07/16	Control Supplement
017939	080	AP	1992/01/07	Labeling Revision
017939	079	AP	1992/08/27	Control Supplement
017939	077	AP	1991/11/13	New or Modified Indication
017939	076	AP	1990/03/21	Package Change
017939	074	AP	1990/05/30	Control Supplement
017939	073	AP	1991/03/07	Labeling Revision
017939	072	AP	1989/06/26	Labeling Revision
017939	071	AP	1989/03/20	Manufacturing Change or Addition
017939	070	AP	1989/06/26	Labeling Revision
017939	068	AP	1988/06/15	Labeling Revision
017939	067	AP	1988/05/20	Labeling Revision
017939	066	AP	1989/11/13	New Dosage Regimen
017939	065	AP	1987/06/03	Manufacturing Change or Addition
017939	064	AP	1988/03/31	New Dosage Regimen
017939	063	AP	1986/07/24	Expiration Date Change
017939	061	AP	1986/04/23	Labeling Revision
017939	059	AP	1986/01/13	Labeling Revision
017939	058	AP	1985/05/15	Labeling Revision
017939	057	AP	1985/04/18	Labeling Revision
017939	056	AP	1985/02/07	Labeling Revision
017939	055	AP	1986/04/29	New Dosage Regimen
017939	054	AP	1985/01/23	Control Supplement
017939	053	AP	1984/06/18	Labeling Revision
017939	052	AP	1984/07/19	Labeling Revision
017939	051	AP	1984/07/11	Package Change
017939	050	AP	1984/03/05	Labeling Revision
017939	049	AP	1984/03/05	Labeling Revision
017939	047	AP	1983/11/29	Labeling Revision
017939	045	AP	1984/07/19	Labeling Revision
017939	044	AP	1984/02/28	Manufacturing Change or Addition
017939	042	AP	1983/02/28	Labeling Revision
017939	041	AP	1983/01/31	General Efficacy (MarkIV)
017939	040	AP	1983/04/22	Manufacturing Change or Addition
017939	039	AP	1985/11/20	New or Modified Indication
017939	038	AP	1982/08/25	General Efficacy (MarkIV)
017939	036	AP	1982/02/04	Labeling Revision
017939	034	AP	1982/01/22	Labeling Revision
017939	033	AP	1981/12/03	Expiration Date Change
017939	032	AP	1982/12/30	Labeling Revision
017939	031	AP	1981/11/02	Labeling Revision
017939	030	AP	1981/07/13	Labeling Revision
017939	028	AP	1981/01/22	Labeling Revision
017939	027	AP	1981/01/22	Labeling Revision
017939	026	AP	1982/12/30	General Efficacy (MarkIV)
017939	025	AP	1980/07/08	Labeling Revision
017939	024	AP	1980/07/08	Labeling Revision
017939	023	AP	1980/07/08	Labeling Revision
017939	021	AP	1980/02/11	Labeling Revision
017939	020	AP	1980/01/17	Control Supplement
017939	019	AP	1981/08/28	Expiration Date Change
017939	018	AP	1980/01/08	Control Supplement
017939	017	AP	1979/04/05	Labeling Revision
017939	016	AP	1979/03/16	Labeling Revision
017939	015	AP	1979/02/01	Labeling Revision
017939	014	AP	1978/12/04	Control Supplement
017939	013	AP	1978/11/30	Labeling Revision
017939	012	AP	1978/11/30	Labeling Revision
017939	010	AP	1978/12/04	Labeling Revision
017939	009	AP	1978/09/28	Labeling Revision
017939	007	AP	1978/09/28	Manufacturing Change or Addition
017939	005	AP	1979/03/16	Labeling Revision
017939	004	AP	1979/03/16	General Efficacy (MarkIV)
017939	003	AP	1977/12/27	Labeling Revision
017939	001	AP	1977/12/27	Labeling Revision
017939	000	AP	1977/08/16	Approval

返回检索页面